Literature DB >> 34859635

Experience in the diagnosis and treatment of a drug-induced pemphigus.

Pei Yang Yuan1, Min Qiu1,2, Zi Xin Wan3, Lu Jiang1.   

Abstract

Drug-induced pemphigus (DIP) is a special type of pemphigus, and its pathogenesis, characteristics of treatment, and prognosis are closely related to the inducing drugs. This article reports the diagnosis and treatment of DIP (pemphigus vulgaris) caused by the administration of rifampin to a patient with tuberculosis. Combined with the literature, we discussed the types, pathogenesis, differential diagnosis, and treatment principles of DIP. We propose that in the oral clinical practice for patients with pemphigus vulgaris, the importance of investigating suspected drugs that induce DIP should be emphasized.

Entities:  

Keywords:  drug-induced pemphigus; pemphigus vulgaris; rifampin; tuberculosis

Mesh:

Substances:

Year:  2021        PMID: 34859635      PMCID: PMC8703096          DOI: 10.7518/hxkq.2021.06.016

Source DB:  PubMed          Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi        ISSN: 1000-1182


  16 in total

1.  Cytokine release and cytotoxicity in human keratinocytes and fibroblasts induced by phenols and sodium dodecyl sulfate.

Authors:  C S Newby; R M Barr; M W Greaves; A I Mallet
Journal:  J Invest Dermatol       Date:  2000-08       Impact factor: 8.551

2.  Pemphigus.

Authors:  D Ioannides; E Lazaridou; D Rigopoulos
Journal:  J Eur Acad Dermatol Venereol       Date:  2008-12       Impact factor: 6.166

3.  Pemphigus induced by rifampicin.

Authors:  R W Gange; E L Rhodes; C O Edwards; M E Powell
Journal:  Br J Dermatol       Date:  1976-10       Impact factor: 9.302

Review 4.  Angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers induced pemphigus: A case series and literature review.

Authors:  Caterina Palleria; Luigi Bennardo; Stefano Dastoli; Luigi F Iannone; Martina Silvestri; Antonia Manti; Steven P Nisticò; Emilio Russo; Giovambattista De Sarro
Journal:  Dermatol Ther       Date:  2018-10-11       Impact factor: 2.851

Review 5.  Tracing the origins of active amide group-positive drug-induced pemphigus vulgaris along the Silk Road: a case report of candesartan-induced pemphigus vulgaris and review of nonthiol drug-induced pemphigus.

Authors:  Yuki Saito; Shujiro Hayashi; Akira Yamauchi; Maki Okamoto; Tomoko Kaminaga; Yoichiro Hamasaki; Atsushi Hatamochi; Ken Igawa
Journal:  Int J Dermatol       Date:  2018-07-05       Impact factor: 2.736

6.  Time course of the changes in prednisolone pharmacokinetics after co-administration or discontinuation of rifampin.

Authors:  K H Lee; J G Shin; W S Chong; S Kim; J S Lee; I J Jang; S G Shin
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

7.  Pemphigus foliaceus induced by rifampicin.

Authors:  C W Lee; J H Lim; H J Kang
Journal:  Br J Dermatol       Date:  1984-11       Impact factor: 9.302

8.  Analysis of 6 cases of drug-induced pemphigus.

Authors:  Suying Feng; Wuqing Zhou; Jiechen Zhang; Peiying Jin
Journal:  Eur J Dermatol       Date:  2011 Sep-Oct       Impact factor: 3.328

9.  Pemphigus vulgaris triggered by rifampin and emotional stress.

Authors:  Ilan Goldberg; Arieh Ingher; Sarah Brenner
Journal:  Skinmed       Date:  2004 Sep-Oct

10.  Biologic therapy-induced pemphigus.

Authors:  Marina Zoega Hayashida; Jhonatan Rafael Siqueira Pinheiro; Milvia Maria Simões E Silva Enokihara; Mônica Ribeiro de Azevedo Vasconcellos
Journal:  An Bras Dermatol       Date:  2017 Jul-Aug       Impact factor: 1.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.